News about Lab Equipment

Okami Medical Enrolls First Patient in ALPHA Registry for LOBO Vascular Occlusion System

The multicentre study will evaluate the safety and effectiveness of the LOBO device in treating peripheral vascular conditions, with plans to enroll up to 500 patients.

Lab Equipment | 08/04/2026 | By News Bureau |  244

Rusan Healthcare Launches APOSAN 3ml Pen for Advanced Parkinson's Treatment in India

The new multi-dose apomorphine delivery device aims to simplify self-administration and improve management of ‘ON-OFF’ episodes in Parkinson’s patients.

Lab Equipment | 02/04/2026 | By News Bureau |  254

AstraZeneca Advances Rare Disease Pipeline with Positive HPP Phase III Data

Alexion, AstraZeneca Rare Disease, has reported positive results from its global Phase III clinical programme evaluating efzimfotase alfa (ALXN1850) in patients with hypophosphatasia (HPP), a rare inherited metabolic disorder.

Lab Equipment | 01/04/2026 | By Darshana |  243

MiniMed Gets FDA Clearance for Smartphone-Controlled Insulin Pump Flex

MiniMed has received clearance from the US Food and Drug Administration (FDA) for its latest insulin delivery device, MiniMed Flex. The new system is a compact, smartphone-controlled insulin pump designed to make diabetes management less visible and easier to handle in everyday life.

Lab Equipment | 20/03/2026 | By Darshana |  206

Qiagen N.V. Receives U.S. Food and Drug Administration Clearance for QIAstat-Dx GI Panels on QIAstat-Dx Rise System

Qiagen N.V. has secured U.S. Food and Drug Administration clearance for QIAstat-Dx GI Panels on its QIAstat-Dx Rise system, enabling laboratories to run respiratory and gastrointestinal syndromic tests on a single automated platform.

Lab Equipment | 13/03/2026 | By News Bureau |  240

Chiesi Group Expands Partnership with Bespak to Scale Up Low-Carbon Inhaler Manufacturing

Chiesi Group and Bespak have expanded their partnership to boost pMDI manufacturing capacity in the UK, supporting the rollout of next-generation Carbon Minimal Inhalers designed to significantly reduce environmental impact.

Lab Equipment | 13/03/2026 | By News Bureau |  277

Novocure secures Japan insurance reimbursement for Optune Lua in advanced lung cancer treatment

Novocure receives reimbursement approval from Japan’s Ministry of Health, Labour and Welfare of Japan for Optune Lua, enabling insured access for advanced NSCLC patients using Tumour Treating Fields therapy.

Lab Equipment | 05/03/2026 | By News Bureau |  248

Astellas-Vir Partnership Advances Dual-Masked T-Cell Engager for Advanced Prostate Cancer

Astellas Pharma Inc. and Vir Biotechnology, Inc. have entered into a global strategic collaboration to develop and commercialize VIR-5500, an investigational PRO-XTEN dual-masked CD3 T-cell engager (TCE) targeting prostate-specific membrane antigen (PSMA) for the treatment of prostate cancer.

Lab Equipment | 25/02/2026 | By Darshana |  218

NOVOS Reports Positive Clinical Trial Results Showing Improvements in Vascular Aging Markers

A randomised clinical trial led by the University of Surrey found that NOVOS Core significantly improved endothelial function, arterial flexibility and systolic blood pressure in adults over 40 compared with placebo.

Lab Equipment | 20/02/2026 | By News Bureau |  670

Hologic's Aptima HPV Assay Receives US FDA Approval for Primary Cervical Cancer Screening

US FDA approves Hologic’s mRNA-based Aptima HPV assay for clinician-collected primary screening, expanding cervical cancer testing options and enhancing early detection of high-risk infections.

Lab Equipment | 07/02/2026 | By News Bureau |  268